Примери за използване на Dengvaxia на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
How does Dengvaxia work?
Other information about Dengvaxia.
What Dengvaxia contains.
How to use Dengvaxia.
Why is Dengvaxia authorised in the EU?
How to store Dengvaxia.
Dengvaxia contains live attenuated viruses.
How is Dengvaxia used?
Other medicines and Dengvaxia.
Dengvaxia is available in packs of 1 or 10.
What are the risks associated with Dengvaxia?
What is Dengvaxia and what is it used for?
If you or your child miss an injection of Dengvaxia.
Reconstitute Dengvaxia with the solvent provided.
No pharmacokinetic studies have been performed on Dengvaxia.
This is because Dengvaxia might not work as well.
Dengvaxia contains weakened viruses that do not cause disease.
Had an allergic reaction after using Dengvaxia before.
Dengvaxia must be reconstituted prior to administration.
Pharmacist or nurse for advice before using Dengvaxia.
Dengvaxia should be used according to official recommendations.
For storage conditions after reconstitution of Dengvaxia, see section 6.3.
Dengvaxia contains weakened viruses that do not cause disease.
In late 2015 and early 2016, the first dengue vaccine, Dengvaxia(CYD- TDV) was registered in several countries for use in individuals 9-45 years of age living in endemic areas.
Dengvaxia is a vaccine used to help protect against dengue disease.
For patients receiving treatment with immunoglobulins or blood products containing immunoglobulins, such as blood or plasma, it is recommended to wait for at least 6 weeks, and preferably for 3 months,following the end of treatment before administering Dengvaxia, in order to avoid neutralization of the attenuated viruses contained in the vaccine.
Dengvaxia is the first licensed vaccine that protects against dengue.
In 2015 the 1st dengue vaccine Dengvaxia®(CYD-TDV) was licensed in 9- 45 years individuals living in endemic areas.
Dengvaxia must not be mixed with other medicinal products in the same syringe.
In late 2015 the first dengue vaccine, Dengvaxia®(CYD-TDV) by Sanofi Pasteur, was registered in several countries for use in individuals aged 9-45 years living in endemic areas[2].